Ra Medical Securities Litigation

Ra Medical Systems (RMED) IPO Stock Settlement

Claim Form Deadline: July 9, 2022

Estimated Payout: Varies

Proof required: Yes

Method of payment: Cash



What's This Settlement About?

A class action settlement has been reached in order to settle a lawsuit against RA Medical Systems Inc and their publically traded stock, RMED listed on NASDAQ. The lawsuit stems from allegations that RA Medical made material misstatements and/or omitted material facts about RA Medical's operations, including product defects with DABRA catheters, product recall, off-label marketing of DABRA, and improper payments to physicians. Pursuant to the Settlement, Defendants have agreed to pay or cause to be paid $10,000,000 in cash.

How Do I Qualify?

The Settlement Class consists of all persons and entities that purchased or otherwise acquired the common stock of RA Medical:

• pursuant and/or traceable to RA Medical's IPO; and/or
• between September 27, 2018 and November 27, 2019, inclusive.

How Do I File a Claim?

To be eligible for a payment from the proceeds of the Settlement, you must be a member of the Settlement Class and you must timely complete and return the Claim Form with adequate supporting documentation online or postmarked no later than July 9, 2022.

The Court will hold a hearing on June 13, 2022 at 11:30 a.m.

Claim Form Website: RAMedicalSecuritiesLitigation.com


Submit Claim Here